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Objectives. Using apocynin (inhibitor of NADPH oxidase), and Mitoquinol 10 nitrate (MitoQ; mitochondrial-targeted antiox-
idant), we addressed the importance of mitochondria versus NADPH oxidase-derived ROS in glucose-induced apoptosis of
pericytes. Methods. NADPH oxidase was localised using Western blot analysis and cytochrome C reduction assay. Apoptosis
was detected by measuring caspase-3 activity. Intracellular glucose concentration, ROS formation and Nε-(carboxymethyl) lysine
(CML)content were measuredusingAmplex Redassaykit,dihydroethidium (DHE),andcompetitive immunoabsorbantenzyme-
linked assay (ELISA), respectively. Results. NADPH oxidase was localised in the cytoplasm of pericytes suggesting ROS production
within intracellular compartments. High glucose (25mM) signiﬁcantly increased apoptosis, intracellular glucose concentration,
and CML content. Apoptosis was associated with increased gp91phox expression, activity of NADPH oxidase, and intracellular
ROS production. Apocynin and not MitoQ signiﬁcantly blunted the generation of ROS, formation of intracellular CML and
apoptosis. Conclusions. NADPH oxidase and not mitochondria-derived ROS is responsible for the accelerated apoptosis of
pericytes in diabetic retinopathy.
1.Introduction
Diabetic retinopathy is a leading cause of blindness that is
characterized by vascular changes of the retinal capillary bed
[1]. One of earliest changes is the accelerated apoptosis of
retinal microvascular cells and the formation of acellular
capillaries [2]. Although, the frequency of pericytes and
endothelial cell apoptosis is thought to predict the devel-
opment of the histological lesions in retinopathy [3], the
underlying cause is not fully understood. Diabetes Control
and Complications Trial (DCCT) and the United Kingdom
Prospective Diabetes Study (UKPDS) have conﬁrmed that
hyperglycaemia is the major factor in the development of
diabetic retinopathy [4, 5]. In addition to the prevailing
biochemical mechanisms [1]o nh o wg l u c o s el e a d st o
pathological changes in retinopathy, recent evidence suggests
a key role for oxidative stress, a state in which excess reactive
oxygen species (ROS) overwhelm endogenous antioxidant
systems [6]. ROS can be produced from the mitochondrial
transport chain and a number of enzymes that are localised
in the plasma membrane, and the cytoplasm of cells [7].
TheelegantstudycarriedoutbyBrownleeandcolleagues
[8] suggests that glucose-induced mitochondria production
of ROS stimulates several of the biochemical mechanism
thought to be involved in hyperglycaemia-mediated com-
plications of diabetes, including retinopathy. The authors
proposed that the causal link between glucose and vascular
damage in diabetes is the increased production of superoxide2 Journal of Ophthalmology
by the mitochondrial electron transport chain [8]. However,
increasing evidence suggests that NADPH oxidase is the
most important source of cellular ROS in blood vessels
[9]. NADPH oxidase complex in neutrophils and, most
probably, endothelial cells and other cell types, involves four
essential subunits. The subunits gp91phox and p22phox
reside in the plasma membrane [9]. These subunits bind the
components of the electron transport chain heme and FAD,
forming cytochrome b558. The cytosolic NADPH oxidase
subunitsp47phoxandp67phoxareinvolvedintheactivation
of the enzyme complex. Unlike the phagocytic type, the
NADPH oxidases present in blood vessels are constitutively
active, producing relatively low levels of ROS under basal
conditions, and generating higher levels of oxidants in
response to cytokines [9]. Among the nonphagocytic cells
examined so far, endothelial NADPH oxidase has been
investigated more extensively [9].
ByusingapocyninandMitoquinol10nitrate(MitoQ)we
addressed the importance of mitochondria versus NADPH
oxidase-derived ROS in glucose-induced apoptosis of cul-
tured retinal capillary pericytes. Apocynin is a methoxy-
substituted catechol that does not act as a ROS scavenger,
but inhibits NADPH oxidase by impeding the assembly
of p47phox and p67phox subunits within the membrane
NADPH oxidase complex [10]. MitoQ which has an antioxi-
dant ubiquinol moiety attached to a triphenylphosphonium
cation by an aliphatic carbon chain is recently developed
mitochondria-targeted antioxidants that selectively block
mitochondrial oxidative damage [11]. The selective accumu-
lation of MitoQ prevents mitochondrial oxidative damage
far more eﬀectively than untargeted antioxidants. It is not
only accumulated by the mitochondria but also can be
regeneratedinitsreducedformbymitochondrial respiratory
chain [11]. Here we show for the ﬁrst time, that it is ROS
derived from NADPH oxidase and not the mitochondria,
which is involved in apoptosis of pericytes induced by
chronic exposure to high glucose.
2.MaterialsandMethods
2.1.CultureofBovineRetinalCapillaryPericytes. Bovinereti-
nal capillary pericytes (BRPs) were established from bovine
retinas dissected from eyes of freshly slaughtered cattle as
described previously in [12]. Brieﬂy, the isolated retinas
were homogenised in serum-free minimal essential medium
(MEM; Sigma, UK), and ﬁltered through 80μm nylon mesh.
The trapped micro vessels were digested with collagenase-
dispase (1mg/ml) for 30min at 37
◦C, ﬁltered through a
45μm nylon mesh and then plated in tissue culture ﬂasks
and maintained in MEM supplemented with 10% foetal
calf serum (FCS), 2mM glutamine, 100IU/ml penicillin,
and 100μg/ml streptomycin. The cells were characterized as
described previously [12] and used at passage 2-3.
Forexperiments,conﬂuentculturesofBRPwereexposed
to continuous normal (5.6mM) glucose and high (25mM)
glucose for 4 days. In some experiments, 500μM apocynin
and 1μM of the mitochondrial targeted antioxidant [11],
MitoQ (quinol attached to triphenylphosphonium; kindly
provided by Dr Murphy, MRC-Dunn Human Nutrition
Unit, Cambridge, UK) was added to normal and high-
glucose medium.
2.2. Caspase-3-Like Activity. Cellular caspase-3 activity was
determined using the colorimetric protease assay. This assay
detects p-nitroanilide (p-NA) photometrically at 405nm
after its cleavage from the colorimetric substrate, N-acetyl-
Asp-Glu-Valp-nitroanilide(Ac-DEVD-pNA)bythecaspase-
3[ 13].
2.3. DNA Fragmentation. DNA fragmentation was quanti-
ﬁed using the Cell Death Detection ELISA plus (1774425;
Roche, Hertfordshire, UK). The assay was carried out
according to manufacturer’s instructions, which measures
mono-, and oligonucleosomes in the cytoplasmic fraction
of cell lysate. The assay was based on a quantitive sandwich
enzyme-immunoassay directed against cytoplasmic histone-
associated DNA fragments.
2.4. Western Blot Analysis. Antibodies directed against
NADPH oxidase subunits, Gp91phox, and p47phox were
from Upstate (UK). After treatment, cells were lysed on
ice in the following lysis buﬀer (20mM Tris-HCL, pH
7.4, 1% Triton X-100, 150mM NaCl, 1mM EDTA, 1mM
EGTA, 0.2mM sodium vanadate, 1mM PMSF, 1μg/ml
aprotinin, 10μg/ml leupeptin). Equal amounts of protein
were separated on 10% polyacrylamide gels and transferred
to Hybond-ECL membranes (Amersham, UK). Membranes
were blocked with 3% bovine serum albumin (BSA) in
phosphate buﬀered saline (PBS) containing 0.05% Tween 20
(PBST). After immunodetection of p47phox, and gp91phox,
the membranes were stripped in a buﬀer containing
50mM Tris, 2% SDS, and 100mM mercaptoethanol at
55
◦C for 30min, washed and immunoblotted with tubulin
antibody (Chemicon, Hampshire, UK). Immunoreactive
bands were quantiﬁed by scanning densitometrically and
calculating the density of individual bands using Image J
software (National Institute of Health, Bethesda, Maryland,
http://rsb.info.nih.gov/ij/). The levels of NADPH oxidase
subunits were expressed as a ratio of intensity of p47phox,
and gp91phox immunoreactive bands/intensity of tubulin
immunoreactive bands.
2.5. Measurement of Intracellular ROS Production. The cell
permeant dihydroethidium (DHE; Molecular Probes) was
used to assess real-time formation of superoxide (O2
−)
in BRP exposed to normal (5.8mM) and high (25mM)
glucose.DHEentersthecellsandisoxidizedbysuperoxideto
form ethidium (ETH), which binds to DNA to produce the
ﬂuorescent ETH-DNA that displays red ﬂuorescence [14].
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stored at −20
◦C. The cells were loaded with 10μM for the
ﬁnal 2h of incubation. The cells were washed with PBS,
lysed with 50μll y s i sb u ﬀer (20mM Tris-HCl, pH 7.4, 1%
Triton X-100, 150mM NaCl, 1mM EDTA, 50mM NaF and
0.2mM sodium orthovanadate) on ice. The lysates were then
transferred into black 96-well plates (Fisher, Loughborough,Journal of Ophthalmology 3
UK) and the ﬂuorescence was measured using spectroﬂuo-
rometer (Plate Chameleon; Hidex, Baringstoke, UK). ETH-
DNA red ﬂuorescence was measured with excitation at
530nm and emission at 616nm. Background ﬂuorescence
intensitywassubtractedfromtheresultsandthelevelofROS
was expressed as ﬂuorescence intensity/μg protein.
2.6. Measurement of NADPH Oxidase Activity. Measurement
of O2
− was based on the capacity to reduce ferricytochrome
c in ferrocytochrome at pH 7.8 [15] .T o t a lc e l ll y s a t e
(50μg protein/experiment), cytochrome c (250μg/l ﬁnal
concentration), and NADPH (100μM) were incubated at
37
◦C for 120min, either in the presence or absence of
diphenyleneiodonium (DPI, 100μM). The reduction of
cytochrome c was measured by reading absorbance at
550nm. O2
− production innmol/mg protein was calculated
from the diﬀerence between absorbance of samples at 0 and
120min and the extinction coeﬃcient 21mmol/l/cm.
2.7. Measurement of Intracellular CML. The intracellular
formation of Nε-(carboxymethyl) lysine (CML) in pericytes
wasquantiﬁedusingcompetitiveimuunoabsorbantenzyme-
linked assay (ELISA) as previously described in [16]. CML-
BSA, used as a standard, was dissolved in 0.05 M carbonate
buﬀer, pH 9.6, to a concentration of 0.5μg/ml. A 50μl
aliquot was added to each well of a 96-well microtitre
ELISA plate (Nunc, Loughborough, UK). After incubation
at 4◦C overnight, the coating solution was discarded and
the wells washed three times with 400μl of PBS containing
0.05% Tween-20 (PBST). The wells were then ﬁlled with
100μl of 2% normal goat serum (NGS) containing 0.1%
BSA for blocking and left for 1h at room temperature.
After washing with three times with 400μl PBST, 50μlo f
the diluted standards and samples were added in triplicate
wells followed by 50μl of the 1:1000 diluted CML-antibody
(Kindly provided by Dr D Ruggiero, INSA, Lyon, France).
After incubation for 2h at room temperature, the wells were
washed three times with 400μl PBST, and developed with
goat antirabbit peroxidase-conjugated IgG (diluted 1:10,000
inPBST)ando-phenylenediamine(Sigma,Dorset,UK).The
absorbance of the samples was read at 490nm and the levels
of CML determined using the standard curve prepared using
various concentrations of CML-BSA.
2.8. Measurement of Intracellular Glucose Concentration.
Aftertreatment,cellswerewashedandmediumwasremoved
and cells lysed. Intracellular glucose concentration was then
determined using Amplex Red Glucose Assay Kit (A 22189;
Molecular Probes, Paisley, UK) according to the manufac-
turer’s instructions. Brieﬂy, 50μl of the reaction solution
(10mM Amplex Red, 10U/ml HRP, 100U/ml glucose oxi-
dase, 50mM sodium phosphate buﬀer, pH 7.4) was added to
50μl of cell lysate in 96-well microtitre plate and incubated
in the dark for 45min at room temperature. The absorbance
was then measured at 560nm using a SpectraMax 190
microplate reader. Intracellular glucose concentration was
determined from a standard curve generated using various
concentrations of glucose.
2.9. Measurement of Protein Kinase Cβ1/2 Activity. Cellu-
lar PKCβ1/2 activity was determined using the TruLight
assay kit (Calbiochem, Nottingham, UK) according to the
manufacturer’s instructions. The activity was based on
ﬂuorescence superquenching and the assay was carried out
in a white 96-well microtitre plates (Nunc, Loughborough,
UK). Fluorescence was measured using microplate reader
(Plate Chameleon, Hidex, Basingstoke, UK) with excitation
at 450nm and emission at 535nm. PKCβ1/2 activity was
calculated from the generated phosphopeptide calibrator
curve and the results expressed PKCβ1/2-dependent phos-
phorylation/mg protein.
2.10. Protein Measurement. Total protein was measured
using the BCA protein assay kit (Pierce, UK).
2.11. Statistical Analysis. The statistical software Graph Pad
Prism version 3.0 was used. A two-tailed Student’s t-test
was used to test the signiﬁcance of paired data. Data are
expressedasmeans ±S.E.Mofmeasurementsinthediﬀerent
experiments. Diﬀerences between groups were considered
statistically signiﬁcant at P<. 05.
3. Results
3.1. Retinal Capillary Pericytes Express NADPH Oxidase.
NADPH oxidase is a membrane-bound enzyme complex
that is a source of cytosolic O2
− a n di sc o m p o s e do fa t
least four subunits, including two important membrane-
bound subunits p22phox and gp91phox and two cytosolic
subunits p47phox and p67phox. On a Western blot, the
antibody directed against the N-terminal peptide labelled
speciﬁcally only one broad band at approximately 80kDa
in lysates of BRP (Figure 1(a)). This immunoreactive band
was detected using the antibody directed against the peptide
corresponding to amino acids 548–560 of human gp91phox.
The antibody also detected similar molecular weight band
in cultured bovine retinal capillary endothelial cells (BREC),
human umbilical endothelial cells (HUVEC), and human
leukocytes (U937 cells) (Figure 1(a)). The anti-gp91phox
antibody used in our study is speciﬁc to human gp91phox
(Nox2) and corresponds to amino acids 548–560 of human
Nox2.
Speciﬁc anti-p47phox also conﬁrmed the presence of
p47phox NADPH oxidase subunit with approximate molec-
ular weight of 55kDa in BRP. An immunoreactive band of
similar weight was also localized in BREC, and HUVEC (Fig-
ure 1(a)). However, in U937 cells the p47phox immunore-
active band had a lower molecular weight of approximately
45kDa. Thus, two major components of a functional
NADPH oxidase are present in BRP.
Immunoblot analysis showed that 48h exposure to high
glucose signiﬁcantly increased gp91phox protein expression
(Figures 1(b) and 1(c)) to 249 ± 38% of normal glucose
(n = 5, P<. 05). In contrast, high glucose failed to cause
a signiﬁcant change in the expression of p47phox (Figures
1(b) and 1(d)).4 Journal of Ophthalmology
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Figure 1: Retinal capillary pericytes express NADPH oxidase. Aliquots of total cellular protein were separated by SDS-PAGE, electrophoret-
ically transferred onto Hybond-ECL membranes. Blots were probed with (a) anti-gp91phox antibody and anti-p47phox antibody. Protein
antibody complexes were detected using secondary antibody conjugated with horseradish peroxidase and the ECL detection system. Lane
1: BRP, lane 2: BREC (bovine retinal capillary endothelial cells), Lane 3: HUVEC (human umbilical vein endothelial cells), and lane 4:
U937 cells (human leukocytes). (b) Representative Western blots of gp91phox, p47phox and tubulin. (c) Expression of gp91phox protein
expression in BRP exposed to high glucose (HG, 25mM) for 48h. Densitometric ratio (intensity gp91phox immunoreactive band/intensity
of the tubulin immunoreactive band) is expressed as % of normal glucose (NG, 5.6mM). (d) Expression of p47phox protein expression
in BRP exposed to high glucose (HG, 25mM) for 48h. Densitometric ratio (intensity of p47phox immunoreactive band/intensity of the
tubulin immunoreactive band) is expressed as % of normal glucose (NG, 5.6mM). Data are represented as Means ± SEM of 3-4 separate
experiments.
∗P <. 05 versus control.
3.2. Glucose Increases NADPH Oxidase Activity. To provide
further and more direct evidence for the eﬀect of high
glucose on NADPH oxidase, cellular activity was measured
using the cytochrome c reduction assay. BRP expresses
active NADPH oxidase (Figure 2(a)). High glucose increased
the NADPH-induced O2
− generation by almost 1.65-fold
compared to normal glucose (Figure 2(b)). The addition of
apocynin (500μM) signiﬁcantly inhibited glucose-induced
NADPH oxidase activity (115 ± 22% of normal glucose,
n = 4, P = .013).
3.3. Glucose Stimulates ROS in Pericytes. Exposure to high
glucose signiﬁcantly increased the intracellular O2
− pro-
duction as detected by ETH-DNA ﬂuorescence (Figure 3).
Oxidant generation increased 126 ± 9% of normal glucose
(n = 6, P<. 05) and was signiﬁcantly reversed by treatment
with 500μM apocynin (101 ± 7% of normal glucose versus
126 ± 9% of normal glucose, n = 6, P<. 05). MitoQ
slightly reversed glucose-induced ROS production (122 ±
4% of normal glucose, n = 6, P = .05).
3.4. Apocynin and Not MitoQ Reverse Glucose-Induced
Apoptosis. Figure 4 compares the eﬀect of high glucose
on apoptosis determined by measuring cellular caspase-3
activity(A)andthelevelofDNAfragmentation(B)usingthe
CellDeathDetectionELISAPlus(Roche,Hertfordshire,UK)
which measures mono- and oligonucleosomes in the cell
lysate. Both assay conﬁrmed high glucose-induced apoptosis
of BRP after 4 days.
AsshowninFigure5,incubationfor4daysincontinuous
high glucose caused a signiﬁcant increase in apoptosis of
pericytes compared to normal glucose (127 ± 9% of normal
glucose, n = 7, P<. 001). This glucose-induced caspase-
3 activity was signiﬁcantly reversed (Figure 5) by 500μM
apocynin (91 ± 7% of normal glucose versus 127 ± 9% of
normalglucose,n = 6−13,P<. 05).Incontrast,theadditionJournal of Ophthalmology 5
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Figure 2: Apocynin reverses glucose-induced NADPH oxidase activity. (a) Cultured bovine retinal capillary pericytes express active NADPH
oxidase. The activity was determined by cytochrome c reduction. Lysate (25μg protein) was added to 250μM cytochrome c in a 96-
well multiwell plate and incubated for 120min, either in the presence or absence of NADPH (100μM) or NADPH oxidase inhibitor
or ﬂavoprotein inhibitor, diphenyleneiodonium (DPI, 100μM). The reduction of cytochrome c was measured by reading absorbance at
550nm (SpectraMax 190). Superoxide (O2
−) production innmol/mg protein was calculated from absorbance of samples and the extinction
coeﬃcient for change of ferricytochrome c to ferrocytochrome c of 21mmol/l/cm. Data are presented as mean ± SEM of 4–6 separate
experiments.
∗P <. 001 versus lysate alone,
∗∗P <. 01 versus lysate with NADPH. (b) Exposure to high glucose for 4 days increases NADPH
oxidase which is signiﬁcantly reversed by the addition of apocynin. Conﬂuent cultures of BRP in 30mm2 dishes were exposed to normal
glucose (NG, 5.6mM) and high glucose (HG, 25mM) with and without 500μM apocynin (HGA) for 4 days. After incubation, the cells were
washed twice with ice-cold PBS; lysed, and NADPH-dependent O2
− production was measured by DPI-inhibitable cytochrome c reduction
assay. Data are presented as mean ± SEM of 4 separate experiments.
∗P <. 05 versus HG.
∗∗P <. 013 versus HG.
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Figure 3: Apocynin reverses continuous high glucose-induced ROS
production in BRP. Subconﬂuent cells in 24-well plate were exposed
tonormalglucose(NG,5.6mM)andcontinuoushighglucose(HG,
25mM) in the absence and presence of 500μM apocynin (HGA)
or 1μM MitoQ (HGMQ) for 3 days. Approximately, 2h before the
end of incubation, DHE (10μM) was added. After the treatment,
the cells were washed twice with PBS, lysed and ﬂuorescence (FL)
intensity was measured. Data are presented as mean ± SEM of 6
separate experiments.
∗P <. 05 versus NG,
∗∗P <. 05 versus HG.
of MitoQ failed to prevent glucose-induced activation of
caspase-3 (124 ± 17% of normal glucose, n = 4).
3.5.IntracellularCMLContentafterExposuretoHighGlucose.
Intracellular levels of CML were quantiﬁed by competitive
enzyme-linked immunoabsorbant assay (ELISA) using spe-
ciﬁc CML antibody. Standard curve was established using
various concentration of CML-BSA. As shown in Figure 6,
exposure to continuous high glucose for 4 days signiﬁcantly
increased the intracellular CML content by almost 2.8-fold
compared to normal glucose (16.3 ± 1.9μg/mg protein
versus 5.9 ± 0.9μg / m gp r o t e i ni nn o r m a lg l u c o s e ,n =
10–12, P<. 05). The addition of apocynin at 500μM,
a concentration that reverses glucose-induced apoptosis,
signiﬁcantlypreventedtheaccumulationofCMLinpericytes
exposed to high glucose (10.7 ± 1.4μg/mg protein versus
16.3 ± 1.9μg / m gp r o t e i ni nh i ghgl u c o s e ,n = 8–12, P<. 05).
In contrast, MitoQ, (1μM) had no signiﬁcant eﬀect on the
CML content in pericytes exposed to high glucose (16.9 ±
5.1μg/mg protein, n = 8).
3.6. Glucose-Induced PKC-β Activity. There was no signif-
icant increase in PKC-β1/β2 activity measured using ﬂuo-
rescence superquenching-based assay. After 4 days exposure,
the activity expressed as PKC-β1/β2-dependent phosphory-
lation/mg protein was found to be 6.9 ± 3.5 (n = 6) in HG
compared to 6.8 ± 3.5 (n = 6).
3.7. Increased Accumulation of Intracellular Glucose after
Exposure to High Glucose. Continuous exposure to high
glucose (25mM) for 4 days increased the intracellular
glucose concentration by almost 6-fold compared to BRP
exposed to normal glucose (92.6 ± 6.0nmol/mg protein
versus 15.2 ± 3.0nmol/mg protein in normal glucose, n =
13-14, P<. 001) (Figure 7). At 500μM, apocynin failed
to prevent the accumulation of intracellular glucose (87.8
± 22.3nmol/mg protein, n = 5). Interestingly, although6 Journal of Ophthalmology
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Figure 4: Continuous high (25mM) glucose induces apoptosis of BRP. Subconﬂuent cells in 30mm2 dishes were exposed to normal (N,
5.6mM) and high (CG, 25mM) glucose for 4 days. (a) High glucose activates caspase-3. After 4 days, the cells were washed twice with
ice-cold PBS, lysed and apoptosis was measured using colorimetric caspase activity assay. Data are represented as Means ± SEM of 6 separate
experiments.
∗P = .0315 versus N. (b) High glucose induces DNA fragmentation. After 4 days, DNA fragmentation was measured using
Cell Death Detection ELISA plus (Roche, Hertfordshire, UK). Data are represented as Means ± SEM of 5 separate experiments. P = .043
versus N.
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Figure 5: Chronic exposure to high glucose induces apoptosis in BRP.
Subconﬂuent cells in 3cm dishes were exposed to normal (NG,
5.6mM) and high (HG, 25mM) glucose in the absence (NG, HG)
and presence of 500μMa p o c y n i n( N G A ,H G A )o r1 μMM i t o Q
(NGMQandHGMQ).After4days,thecellswerewashedtwicewith
ice-cold PBS, lysed and apoptosis was measured using colorimetric
caspase-3 activity. Data are represented as Means ± SEM of 3–6
separate experiments.
∗P <. 05 versus NG,
∗∗P <. 05 versus HG.
MitoQ (1μM) failed to prevent the activation of caspase-
3, it signiﬁcantly lowered the level of intracellular glucose
concentration in BRP exposed to high glucose (57.9 ±
8.6nmol/mg protein versus 92.6 ± 6.0nmol/mg protein in
high glucose, n = 5–13, P<. 05). However, apocynin and
MitoQ did not alter the intracellular glucose concentration
in BRP exposed to normal glucose.
4. Discussion
There is now growing evidence that oxidative stress plays
an important role in the pathogenesis of chronic compli-
cations of diabetes [6], but the exact source, and cellular
NG HG HGA HGMQ
0
10
20
30
C
M
L
-
m
o
d
i
ﬁ
e
d
p
r
o
t
e
i
n
(
µ
g
/
m
g
p
r
o
t
e
i
n
)
∗
∗∗
Figure 6: Apocynin reverses glucose-induced CML formation in BRP.
Subconﬂuent cells in 24-well plate were exposed to normal glucose
(NG, 5.6mM) and continuous high glucose (HG, 25mM) and in
t h ep r e s e n c eo f5 0 0μMa p o c y n i n( H G A )o r1μMM i t o Q( H G M Q )
for 4 days. After incubation, the cells were washed twice with ice-
cold PBS, lysed and CML were detected using competitive ELISA.
Data are presented as Mean ± SEM of 8–13 samples.
∗P <. 05
versus NG,
∗∗P <. 05 versus HG.
locationoftheglucose-inducedROSisstillunclear.Brownlee
and co-workers proposed that in cultured macrovascular
bovine aortic endothelial cells (BAECs), the production
of ROS by the mitochondria via the respiratory chain is
the most important causal link between high glucose and
the main pathways responsible for hyperglycaemic damage
[8]. Besides mitochondria, NADPH oxidase also generates
a signiﬁcant amount of ROS and is a major source of
superoxide in vascular cells [9]. In the present study, we used
apocynin, an inhibitor of NADPH oxidase [10]a n dM i t o Q ,
a mitochondria-targeted antioxidant [11, 12], to explore
the importance of mitochondria versus NADPH oxidaseJournal of Ophthalmology 7
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Figure 7: Exposure to high glucose increases intracellular glucose
concentration. Subconﬂuent cells in 24-well plate were exposed to
normal glucose (NG, 5.6mM) and high glucose (HG, 25mM)
and in the presence of 500μMa p o c y n i n( N G A ,H G A )o r1 μM
MitoQ (NGMQ, HGMQ) for 4 days. The cells were washed twice
with ice-cold PBS, lysed and intracellular glucose concentrations
were measured using the Amplex Red glucose assay kit (Molecular
Probe). Data are Means ± SEM of 5–14 separate experiments.
∗P <
.001 versus NG;
∗∗P <. 05 versus HG.
derived ROSin glucose-induced apoptosis of culturedretinal
capillary pericytes.
Our observations of glucose-induced apoptosis of per-
icytes is consistent with previous in vitro studies [17–20]
and the activation of caspase-3 in the retina of diabetic
animals and humans [21, 22]. Consistent with recent reports
[23, 24], retinal capillary pericytes express NADPH oxidase
as indicated by the immunoblotting of Nox2 and p47phox,
major membrane and cytosolic subunits [9, 10], respectively.
In contrast, Manea et al. [24] using reverse transcriptase-
polymerase chain reaction (RT-PCR) detected Nox1 and
Nox2 in pericytes isolated from rat adipose tissue microvas-
culature.Since Nox2 and Nox1 shows only 56% of homology
[25], we safely assume that our antibody does not cross-
react with Nox1. NADPH oxidase, as in other cell types [26,
27] could be mostly present in the cytoplasm of pericytes,
suggesting that ROS is produced within the intracellular
compartments.Although,glucoseincreasedNADPHoxidase
via Nox2 expression, the exact mechanism of control is at
present unclear. In support of our observations, increased
mRNAand/orproteinlevelsofgp91phoxhavebeenreported
in blood vessels from animals [28, 29] and patients with
diabetes [30]. As reported in other cell types [22, 31, 32],
exposure to high glucose increased NADPH oxidase activity
and ROS production in pericytes. In addition to changes in
the expression of NADPH oxidase subunits [33, 34], high
glucose could stimulate ROS production through protein
kinase C (PKC)-dependent phosphorylation of the p47phox
subunit [32]. The β isoform of PKC has been implicated
in the phosphorylation of p47phox [33], but in our study,
we failed to demonstrate activation of PKCβ1/2 in pericytes
exposed to high glucose.
Our ﬁndings of increased oxidative stress in response
to high glucose is in line with some previous studies
[20, 23], but it appears to argue against a recent report
suggesting that pericytes are resistant to glucose-induced
oxidative stress [35]. The reason for this inconsistency is at
present unclear. Our results show that ROS derived from
NADPH oxidase and not the mitochondria, is involved in
caspase-3-mediated apoptosis of pericytes induced by high
glucose. This possibility is supported by recent studies [36]
demonstrating the potential of apocynin to block glucose-
induced ROS in BAEC. Other workers have demonstrated
the role of NADPH oxidase in diabetic retinopathy [36–
39], and complications of diabetes [40, 41] including the
loss of podocytes in diabetic nephropathy [42]. Results
with MitoQ suggested that some ROS is produced from
the mitochondria, but it does not play a signiﬁcant role in
glucose-induced apoptosis. The mitochondria is known to
play a key role in activating apoptosis through enhanced
cytochrome (cyt c) release resulting in the activation of
caspases and subsequent cell death [43]. Apoptotic cell
death is mediated by stimulated caspase-3 activity, and
the accumulation of p53, a known signalling molecule
that acts upstream of caspase-3. Although, there is no
direct evidence available to show that ROS derived from
NADPH oxidase interact with mitochondria, we suggest
that there is some interaction in pericytes exposed to high
glucose.
In bovine aortic endothelial cells (BAECs) the mito-
chondria-derived ROS was also involved in glucose-induced
intracellular AGE formation [6]. However, our observation
that apocynin reverses glucose-induced Nε-(carboxymethyl)
lysine(CML)production,suggestsaroleofNADPHoxidase-
derived ROS in the formation of intracellular CML-modiﬁed
proteins in pericytes exposed to high glucose. In support of
this, there is evidence that phagocytic NADPH oxidase plays
animportantroleinCMLformationinvivo[44].SinceCML
is a biomarker of cellular oxidative stress [45], it may explain
our previous failure to observe intracellular formation of
AGEs, as detected using AGE-antibody [16]i np e r i c y t e s
exposed to high glucose. As reported previously [16, 46,
47] intracellular glucose levels were signiﬁcantly increased
in pericytes exposed to high glucose. During the initial
step of auto-oxidative glycation, ROS fragments glucose to
generate glyoxal with potential to react and form CML on
lysineresiduesofintracellularandextracellularproteins[48].
The formation of CML from intermediates of the Mailard
reaction, such as Schiﬀ’s base and the Amadori product that
are raised in pericytes exposed to high glucose [16], requires
ROS-mediated oxidative cleavage of the carbon backbone
[49]. Although, ROS controls the formation of intracellular
CML, its role in glucose-induced apoptosis is unclear, but
may be involved in the observed reduced proliferation and
increased necrosis of pericytes in high glucose. This notion is
supported by a recent study showing that CML-modiﬁcation
of histones is associated with decreased proliferation of
keratinocytes exposed to glyoxal [50]. Intracellular forma-
tion of CML in pericytes could well be important since
increased levels of CML are present in the retina of rats
with experimental diabetes [51] and levels in lymphocytes
are associated with the pathogenesis of diabetic retinopathy
[52].8 Journal of Ophthalmology
In summary, we have demonstrated for the ﬁrst time
that in contrast to BAEC, ROS from NADPH oxidase and
not the mitochondria plays a key role in glucose-induced
intracellular formation of CML and apoptosis of retinal
capillary pericytes. The results support the recent reports
linking NADPH oxidase and diabetic retinopathy [39]a n d
the beneﬁcial eﬀect of antioxidants to prevent oxidative
stress and caspase-3-dependent apoptosis of pericytes [19].
Speciﬁc pharmacological NADPH oxidase inhibitors might
also be of potential use during the treatment of early diabetic
retinopathy.
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